Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Return on Assets (2016 - 2025)

Historic Return on Assets for Myriad Genetics (MYGN) over the last 15 years, with Q3 2025 value amounting to 0.57%.

  • Myriad Genetics' Return on Assets fell 4600.0% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57%, marking a year-over-year decrease of 4600.0%. This contributed to the annual value of 0.12% for FY2024, which is 1100.0% up from last year.
  • As of Q3 2025, Myriad Genetics' Return on Assets stood at 0.57%, which was down 4600.0% from 0.47% recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Return on Assets ranged from a high of 0.01% in Q1 2022 and a low of 0.57% during Q3 2025
  • For the 5-year period, Myriad Genetics' Return on Assets averaged around 0.16%, with its median value being 0.12% (2021).
  • As far as peak fluctuations go, Myriad Genetics' Return on Assets surged by 1500bps in 2021, and later plummeted by -4600bps in 2025.
  • Over the past 5 years, Myriad Genetics' Return on Assets (Quarter) stood at 0.02% in 2021, then crashed by -354bps to 0.09% in 2022, then tumbled by -147bps to 0.23% in 2023, then surged by 47bps to 0.12% in 2024, then tumbled by -372bps to 0.57% in 2025.
  • Its Return on Assets stands at 0.57% for Q3 2025, versus 0.47% for Q2 2025 and 0.1% for Q1 2025.